Detection of Chemotherapy-Resistant Pancreatic Cancer Using a Glycan Biomarker
C. Gao, L. Wisniewski, Y. Liu, B. Staal, I. Beddows, D. Plenker, M. Aldakkak, J. Hall, D. Barnett, M. Kheir Gouda, P. Allen, R. Drake, A. Zureikat, Y. Huang, D. Evans, , B. Haab
This paper identifies sTRA as a glycan biomarker for chemotherapy-resistant pancreatic cancer, showing its presence correlates with poor treatment response in multiple systems.
bioRxiv · Jun 1, 2020 · PreprintCancer Biology